Development of image analysis system for quantitative evaluation of neurite degeneration

神经突变性定量评价图像分析系统的开发

基本信息

  • 批准号:
    13557203
  • 负责人:
  • 金额:
    $ 9.02万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2003
  • 项目状态:
    已结题

项目摘要

We constructed an experimental system for quantitative evaluation of neuronal morphology by on-line image analysis of central neurons in dissociated or organotypic cultures, thereby investigated neuronal degeneration and neuroprotection. (1) We prepared retinal tissue cultures from neonatal rats that received DiI injection into the superior colliculus, and observed morphology of retinal ganglion cells (RGCs). RGCs were identified as bright fluorescent spots aligned in one focal plane within the retina. The number and size of fluorescent spots gradually decreased during the course of cultivation. Cycloheximide or actinomycin D markedly inhibited the decrease in the number of viable RGCs. DEVD, a selective caspase-3 inhibitor, also significantly inhibited the decrease in RGC viability, and DNA fragmentation was found to be restricted in the ganglion cell layer. These results indicate that the gradual decrease in RGC viability results from induction of apoptosis. Moreover, nitric oxide de … More rived from neuronal nitric oxide synthase (NOS) was shown to play an important role in induction of apoptosis in RGCs, because an NOS inhibitor L-NAME as well as a relatively selective neuronal NOS inhibitor 7-nitroindazole markedly inhibited the decrease in RGC viability. (2) We found that cultivation of midbrain slice cultures with medium containing high concentrations of Mg^<2+> or that containing NMDA receptor antagonists resulted in a drastic decrease in the number of dopaminergic neurons. There were also prominent atrophic changes in neurites of dopaminergic neurons remaining after these treatments. Co-application of an adenylyl cyclase activator or a cyclic AMP analog abolished the effects of chronic Mg^<2+> and NMDA antagonists. These results suggest that moderate activation of NMDA receptors associated with spontaneous neuronal activity makes significant contribution to early development and maintenance of midbrain dopaminergic neurons, where cyclic AMP-related intracellular signaling plays a key role. Less
我们构建了一个实验系统,通过在线图像分析的神经元形态定量评价在分离或器官型培养的中枢神经元,从而研究神经元变性和神经保护。(1)将DiI注射到新生大鼠的上级丘,制备视网膜组织培养物,观察视网膜神经节细胞(RGCs)的形态。RGC被识别为在视网膜内的一个焦平面上对齐的明亮荧光斑点。在培养过程中,荧光点的数量和大小逐渐减少。放线菌酮或放线菌素D显着抑制活性RGCs数量的减少。DEVD,一种选择性的半胱天冬酶-3抑制剂,也显着抑制RGC活力的下降,DNA片段被发现限制在神经节细胞层。这些结果表明,RGC活力的逐渐降低是由细胞凋亡的诱导引起的。此外,一氧化氮 ...更多信息 来源于神经元型一氧化氮合酶(NOS)的一氧化氮合酶(NOS)抑制剂L-NAME和相对选择性的神经元型NOS抑制剂7-硝基吲唑(7-nitroindazole)可显著抑制RGC活力的下降,从而在诱导RGC凋亡中发挥重要作用。(2)我们发现,用含有高浓度Mg^<2+>或含有NMDA受体拮抗剂的培养基培养中脑切片,可导致多巴胺能神经元数量的急剧减少。这些处理后,多巴胺能神经元的轴突也有明显的萎缩变化。同时应用腺苷酸环化酶激活剂或环腺苷酸类似物可消除慢性Mg^<2+>和NMDA拮抗剂的作用。这些结果表明,与自发神经元活动相关的NMDA受体的适度激活对中脑多巴胺能神经元的早期发育和维持做出了重大贡献,其中环AMP相关的细胞内信号传导起着关键作用。少

项目成果

期刊论文数量(226)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ibi, M. et al.: "Protective effects of 1α,25-(OH)_2D_3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture"Neuropharm.. 40. 761-771 (2001)
Ibi, M. 等人:“1α,25-(OH)_2D_3 对中脑培养物中谷氨酸和活性氧的神经毒性的保护作用” Neuropharm.. 40. 761-771 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Taguchi, R. et al.: "Serofendic acid prevents acute glutamate neurotoxicity in cultured cortical neurons."Eur.J.Pharmacol.. 477. 195-203 (2003)
Taguchi, R. 等人:“Serofendic Acid 可预防培养的皮质神经元中的急性谷氨酸神经毒性。”Eur.J.Pharmacol.. 477. 195-203 (2003)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Wang, X. et al.: "Vitamin B6 protects primate retinal neurons from ischemic injury."Brain Res.. 940. 36-43 (2002)
Wang, X. 等人:“维生素 B6 保护灵长类动物视网膜神经元免受缺血性损伤。”Brain Res.. 940. 36-43 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamauchi, T. et al.: "Mitochondrial ATP-sensitive potassium channel : a novel site for neuroprotection."Inv.Ophtalmol.Vis.Sci.. 44. 2750-2756 (2003)
Yamauchi, T. 等人:“线粒体 ATP 敏感钾通道:神经保护的新位点。”Inv.Ophtalmol.Vis.Sci.. 44. 2750-2756 (2003)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamauchi, T. et al.: "Mitochondrial ATP-sensitive potassium channel : a novel site for neuroprotection"Invest.Ophthalmol.Vis.Sci.. 44(6). 2750-2756 (2003)
Yamauchi, T. 等人:“线粒体 ATP 敏感钾通道:神经保护的新位点”Invest.Ophasemol.Vis.Sci.. 44(6)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AKAIKE Akinori其他文献

AKAIKE Akinori的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AKAIKE Akinori', 18)}}的其他基金

Establishment of hypoxia-induced brain ischemia-reperfusion model in zebrafish larvae
斑马鱼幼鱼缺氧脑缺血再灌注模型的建立
  • 批准号:
    25670036
  • 财政年份:
    2013
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Elucidation of neuroprotective mechanisms of low molecular weight compounds
阐明低分子量化合物的神经保护机制
  • 批准号:
    21390175
  • 财政年份:
    2009
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Roles of low-molecular weight bioactive factors in the protective mechanisms of brain function
低分子生物活性因子在脑功能保护机制中的作用
  • 批准号:
    19390152
  • 财政年份:
    2007
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Protective mechanisms of endogenous bioactive molecules on neuronal death associated with neurodegenerative disorders
内源性生物活性分子对神经退行性疾病相关神经元死亡的保护机制
  • 批准号:
    14370780
  • 财政年份:
    2002
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of endogenous protective factors regulating neuronal death in neurodegenerative disorders.
阐明调节神经退行性疾病中神经元死亡的内源性保护因子。
  • 批准号:
    12470524
  • 财政年份:
    2000
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanisms of protectiion by neurotrophins against NO-mediated glutamate neurotoxicity
神经营养素对 NO 介导的谷氨酸神经毒性的保护机制
  • 批准号:
    09470502
  • 财政年份:
    1997
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of analyzing softwere of neuronal death model in primary cultured cells
原代培养细胞神经元死亡模型分析软件的开发
  • 批准号:
    07557328
  • 财政年份:
    1995
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of Nitric Oxide in neuronal death and its modulation by neuroprotective factors
一氧化氮在神经元死亡中的作用及其神经保护因子的调节
  • 批准号:
    07457539
  • 财政年份:
    1995
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Inflammatory Signaling and Regeneration in Zebrafish models of Retinal Degeneration
视网膜变性斑马鱼模型中的炎症信号传导和再生
  • 批准号:
    10751153
  • 财政年份:
    2023
  • 资助金额:
    $ 9.02万
  • 项目类别:
Understanding the Role of GARP Proteins in Rod Outer Segment Disc Formation and Retinal Degeneration
了解 GARP 蛋白在视杆外节盘形成和视网膜变性中的作用
  • 批准号:
    10748725
  • 财政年份:
    2023
  • 资助金额:
    $ 9.02万
  • 项目类别:
Electronic photoreceptors for restoration of sight in retinal degeneration
电子感光器用于视网膜退化患者恢复视力
  • 批准号:
    10708374
  • 财政年份:
    2023
  • 资助金额:
    $ 9.02万
  • 项目类别:
The role of iron in retinal degeneration during bacterial infection
铁在细菌感染期间视网膜变性中的作用
  • 批准号:
    10676039
  • 财政年份:
    2023
  • 资助金额:
    $ 9.02万
  • 项目类别:
Retinal Degeneration Conference
视网膜变性会议
  • 批准号:
    10785476
  • 财政年份:
    2023
  • 资助金额:
    $ 9.02万
  • 项目类别:
Therapeutic Editing of Rod Glycolysis Rescues Retinal Degeneration
杆状糖酵解的治疗性编辑可挽救视网膜变性
  • 批准号:
    10607717
  • 财政年份:
    2023
  • 资助金额:
    $ 9.02万
  • 项目类别:
Expert curation of clinically significant variants in genes for early onset retinal degeneration
专家对早发性视网膜变性基因的临床显着变异进行管理
  • 批准号:
    10655529
  • 财政年份:
    2022
  • 资助金额:
    $ 9.02万
  • 项目类别:
Global Research & Development of Novel Nano-Particle Medicine Targeting Monocytes/Macrophages Against Retinal Degeneration
全球研究
  • 批准号:
    22KK0136
  • 财政年份:
    2022
  • 资助金额:
    $ 9.02万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
Developing gene editing platforms for retinal degeneration.
开发视网膜变性的基因编辑平台。
  • 批准号:
    10522389
  • 财政年份:
    2022
  • 资助金额:
    $ 9.02万
  • 项目类别:
Developing gene editing platforms for retinal degeneration.
开发视网膜变性的基因编辑平台。
  • 批准号:
    10707472
  • 财政年份:
    2022
  • 资助金额:
    $ 9.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了